汇宇制药：股东减持股份计划公告

Core Points - Huayu Pharmaceutical announced that shareholder Wang Xiaopeng holds 17,037,557 shares, accounting for 4.022% of the total share capital [2] - Wang Xiaopeng plans to reduce her holdings by up to 12,708,000 shares, representing a maximum reduction of 3% of the total shares [2] - The reduction period is set for three months starting from 15 trading days after the announcement [2]